Replay available

Viridian Therapeutics, Inc. (VRDN) Q3 2022 Earnings Call

Viridian Therapeutics, Inc. (NASDAQ: VRDN) Q3 2022 earnings conference call, held 2022-11-14. Replay captured from the company's public earnings webcast.

Mon, November 14, 2022 at 8:00 AMendedReplay
Viridian Therapeutics, Inc.  (VRDN) Q3 2022 Earnings Call

Hosted by

Featured presenters

John Jordan

Vice President of Investor Relations

Dr. Jonathan Violin

President and CEO

Dr. Barry Katz

Chief Medical Officer

Christian Humer

Chief Financial Officer and Chief Business Officer

Rami Kathuda

Analyst, LifeSci Capital

Gavin Clark Gardner

Analyst, Evercore ISI

Thomas Smith

Analyst, SVB Securities

Laura Chico

Analyst, Wedbush Securities

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Viridian Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.292 Greetings and welcome to Viridian Therapeutics third quarter 2022 00:00:05.292 -- 00:00:10.355 earnings call. At this time, all participants are in a listen only 00:00:10.355 -- 00:00:16.218 mode. A question and answer session will follow the formal presentation. 00:00:16.218 -- 00:00:20.880 If anyone should require operator assistance during the conference, please press star 00:00:20.880 -- 00:00:23.782 zero on your telephone keypad. 00:00:23.782 -- 00:00:26.243 As a reminder, this conference is being recorded. 00:00:26.243 -- 00:00:29.983 I would now like to turn the conference over to your host. 00:00:29.983 -- 00:00:33.065 John Jordan, Vice President of Investor Relations. 00:00:33.065 -- 00:00:33.606 Please go ahead. 00:00:33.606 -- 00:00:35.606 Thank 00:00:35.827 -- 00:00:39.650 you, Brock. Good morning, everyone, and welcome to the Viridian conference call to discuss 00:00:39.650 -- 00:00:44.652 the positive clinical data report earlier today for VRDN001 00:00:44.733 -- 00:00:47.914 in patients with thyroid eye disease. 00:00:48.216 -- 00:00:52.298 Before we begin, I'd like to remind everyone that this conference call and webcast will 00:00:52.298 -- 00:00:55.143 contain forward-looking statements about the company. 00:00:55.143 -- 00:00:59.884 These statements are subject to risks and uncertainties that could cause actual results 00:00:59.884 -- 00:01:04.425 to differ. Please note that these forward-looking statements reflect our opinions only 00:01:04.425 -- 00:01:06.626 as of today. 00:01:06.626 -- 00:01:12.007 Except as required by law, we specifically disclaim any obligation to update or revise 00:01:12.007 -- 00:01:16.348 these forward-looking statements in light of new information or future events. 00:01:16.348 -- 00:...